MultiDIP®
In silico platform to predict and characterise ADME-T compound parameter.
Welcome
On the website BioQuanta
BioQuanta is a biotechnology company specialized in biology and molecular modeling. Our expertise in these fields has enabled us to develop unique service platforms for the health sciences, cosmetics, and agro-sciences sectors.
We also apply our know-how to developing new biomarkers and diagnostic kits for clinical biology.
BioQuanta offers two unique service platforms – MultiDIP® and Mitoxis®.
- MultiDIP® is a modeling system for predicting and understanding the toxicity and ADME parameters of any molecule (e.g. from therapeutic or cosmetics development). MultiDIP® can be applied to the standard phases of drug development, from discovery to lead optimization. A detailed understanding of molecular properties and activity can also enable the repositioning of an existing drug. MultiDIP®’s toxicity predictions can also be applied to REACH compliance.
- Mitoxis® is a novel assay platform for evaluating the metabolic impact of any molecule, as well as detecting mitochondrial toxicity.
MultiDIP® and Mitoxis® are complementary service offerings that enable you to identify molecules that are efficacious and non-toxic. The accuracy and reliability of our results allows you to accelerate R&D, reduce development costs, and reduce the risk of late-stage attrition.
BioQuanta uses this same technology, expertise, and innovation to discover new biomarkers and develop diagnostic kits to use them.
Mitoxis®
In vitro platform for in-depth investigation of compound effect on cellular metabolism.
Mitoxis®
Plateforme in vitro pour une exploration approfondie des effets induits par des composés sur le métabolisme cellulaire.
